Skip to content
Research Article Open access CC BY 4.0

Impact of Glycosylation on Therapeutic Glycoproteins

Mohaddesseh Mousavi, Moein Dehbashi, Ali Movahedi

Current Journal of Applied Science and Technology · pp. 1–16 · Published 16 Nov 2016

10.9734/BJAST/2016/29679

Abstract

Therapeutic glycoproteins, which are produced in different expression systems are effective as biopharmaceuticals in medical applications and glycan engineering technology can open a new world to facilitate production of these proteins to overcome some pharmacological problems by humanizing the biopharmaceuticals. Also, the recognition of the role of glycosylation upon proteomics inconstancies of therapeutic proteins under manufacturing is critical for safety and non-immunogenic production. In this review, we tried to describe some important therapeutic glycoproteins and focused on some proteomics challenges of these proteins, which are improved by glycosylation.

Therapeutic glycoproteins glycosylation glycan engineering

Cited by 1

1 citation reported by external sources — individual citing-article records aren't available to list yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

1

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.